High-dose biologics and bioconjugates delivery: Integrating molecular optimization with device design and routes of administration.

AOC-Pompe Disease - Eli Lilly, Avidity Biosci

http://www.ncbi.nlm.nih.gov/pubmed/42114653

Abraham H Abouzeid; Chris Mitchener; Elisa Schrader Echeverri; J Anand Subramony; Kevin Harrison Duffy; Naresh K Budhavaram; Nisha Shrestha; Reshma Bharadwaj

May 12, 2026